253 related articles for article (PubMed ID: 17068108)
1. Teratogen-induced activation of p53 in early postimplantation mouse embryos.
Hosako H; Little SA; Barrier M; Mirkes PE
Toxicol Sci; 2007 Jan; 95(1):257-69. PubMed ID: 17068108
[TBL] [Abstract][Full Text] [Related]
2. Teratogen-induced activation of the mitochondrial apoptotic pathway in the yolk sac of day 9 mouse embryos.
Soleman D; Cornel L; Little SA; Mirkes PE
Birth Defects Res A Clin Mol Teratol; 2003 Feb; 67(2):98-107. PubMed ID: 12769505
[TBL] [Abstract][Full Text] [Related]
3. Teratogen-induced activation of ERK, JNK, and p38 MAP kinases in early postimplantation murine embryos.
Mirkes PE; Wilson KL; Cornel LM
Teratology; 2000 Jul; 62(1):14-25. PubMed ID: 10861629
[TBL] [Abstract][Full Text] [Related]
4. Teratogen-induced activation of caspase-9 and the mitochondrial apoptotic pathway in early postimplantation mouse embryos.
Little SA; Mirkes PE
Toxicol Appl Pharmacol; 2002 Jun; 181(2):142-51. PubMed ID: 12051998
[TBL] [Abstract][Full Text] [Related]
5. Alterations in gene expression induced in day-9 mouse embryos exposed to hyperthermia (HS) or 4-hydroperoxycyclophosphamide (4CP): analysis using cDNA microarrays.
Mikheeva S; Barrier M; Little SA; Beyer R; Mikheev AM; Kerr MK; Mirkes PE
Toxicol Sci; 2004 Jun; 79(2):345-59. PubMed ID: 14976350
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome c release from mitochondria of early postimplantation murine embryos exposed to 4-hydroperoxycyclophosphamide, heat shock, and staurosporine.
Mirkes PE; Little SA
Toxicol Appl Pharmacol; 2000 Feb; 162(3):197-206. PubMed ID: 10652248
[TBL] [Abstract][Full Text] [Related]
7. Teratogen-induced activation of caspase-6 and caspase-7 in early postimplantation mouse embryos.
Little SA; Kim WK; Mirkes PE
Cell Biol Toxicol; 2003 Aug; 19(4):215-26. PubMed ID: 14686614
[TBL] [Abstract][Full Text] [Related]
8. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
9. The roles of p53 and p21 in normal development and hyperthermia-induced malformations.
Hosako H; Francisco LE; Martin GS; Mirkes PE
Birth Defects Res B Dev Reprod Toxicol; 2009 Feb; 86(1):40-7. PubMed ID: 19140129
[TBL] [Abstract][Full Text] [Related]
10. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
[TBL] [Abstract][Full Text] [Related]
11. Actinomycin D upregulates proapoptotic protein Puma and downregulates Bcl-2 mRNA in normal peripheral blood lymphocytes.
Kalousek I; Brodska B; Otevrelova P; Röselova P
Anticancer Drugs; 2007 Aug; 18(7):763-72. PubMed ID: 17581298
[TBL] [Abstract][Full Text] [Related]
12. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
13. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata.
Bhushan S; Malik F; Kumar A; Isher HK; Kaur IP; Taneja SC; Singh J
Mol Carcinog; 2009 Dec; 48(12):1093-108. PubMed ID: 19544329
[TBL] [Abstract][Full Text] [Related]
14. Alterations in mitochondrial morphology are associated with hyperthermia-induced apoptosis in early postimplantation mouse embryos.
Kim WK; Mirkes PE
Birth Defects Res A Clin Mol Teratol; 2003 Nov; 67(11):929-40. PubMed ID: 14745931
[TBL] [Abstract][Full Text] [Related]
15. Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways.
Shibue T; Suzuki S; Okamoto H; Yoshida H; Ohba Y; Takaoka A; Taniguchi T
EMBO J; 2006 Oct; 25(20):4952-62. PubMed ID: 17024184
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the molecular mechanisms for p53-mediated differentiation.
Chylicki K; Ehinger M; Svedberg H; Gullberg U
Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress.
Jiang CC; Lucas K; Avery-Kiejda KA; Wade M; deBock CE; Thorne RF; Allen J; Hersey P; Zhang XD
Cancer Res; 2008 Aug; 68(16):6708-17. PubMed ID: 18701495
[TBL] [Abstract][Full Text] [Related]
18. Effect of maternal immunopotentiation on apoptosis-associated molecules expression in teratogen-treated embryos.
Savion S; Aroch I; Mammon K; Orenstein H; Fein A; Torchinsky A; Toder V
Am J Reprod Immunol; 2009 Dec; 62(6):400-11. PubMed ID: 19895375
[TBL] [Abstract][Full Text] [Related]
19. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
